NCT07305571

Brief Summary

Aims This study examined the effect of psychodrama-based group work on postpartum women's tendencies toward depression and forgiveness. Methods This study used a pretest-posttest-follow-up randomised controlled experimental method. The study sample consisted of 23 postpartum mothers (11 experimental and 12 control) whose babies were receiving treatment in the neonatal intensive care unit between April and June 2025. While psychodrama-based group intervention was applied to the experimental group, no intervention was performed in the control group. Data were collected using a personal information form, Postnatal Depression Screening Scale, and Forgiveness Scale. Results In the study, it was found that the mean forgiveness scores in the final test and follow-up measurements of the postpartum women in the experimental group were statistically significantly higher compared to the control group (p\<0.05). In the final test and follow-up measurements, the mean postpartum depression scores of the women in the experimental group were found to be statistically significantly lower than those of the mothers in the control group (p\<0.05). Conclusions Psychodrama-based group work increased forgiveness tendencies and reduced depression levels in postpartum women. In this regard, it is recommended that psychodrama sessions be conducted for postpartum women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 2, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 13, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 26, 2025

Completed
Last Updated

January 6, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

December 13, 2025

Last Update Submit

January 2, 2026

Conditions

Keywords

depressionforgivenesspsychodramapuerperalpsychiatric nursing

Outcome Measures

Primary Outcomes (1)

  • Postpartum Depression Screening Scale

    Evaluation of the change in the total score of the Postpartum Depression Screening Scale. The minimum score obtained from the scale was 35, and the maximum score was 175. Higher scores indicate higher levels of postpartum depression.

    Baseline (pretest), 8 weeks (posttest) and one month after the posttest

Secondary Outcomes (1)

  • The Forgiveness Scale

    Baseline (pretest), 8 weeks (posttest) and one month after the posttest

Study Arms (2)

psychodrama-based group intervention

EXPERIMENTAL

Participants will receive an 8-session psychodrama-based group intervention.

Other: psychodrama-based group interventionOther: Control

Control

NO INTERVENTION

Throughout the study, the psychodrama-based group intervention was applied only to the experimental group, and no intervention was performed in the control group

Interventions

For postpartum mothers in the experimental group, a psychodrama-based group intervention was carried out face-to-face, with one session per week, each lasting 120 minutes, for a total of 8 sessions (over 8 weeks).

psychodrama-based group intervention
ControlOTHER

no intervention was performed in the control group

psychodrama-based group intervention

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18-55 years or (until menopause)
  • Having the mental capacity and sufficient communication skills to follow the research instructions, being literate.
  • Having an infant receiving treatment in the neonatal intensive care unit.

You may not qualify if:

  • Having a condition that impairs communication
  • Having a diagnosed mental illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bergama Necla Mithat Öztüre State Hospital

Izmir, Bergama, 35700, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Depression, PostpartumDepression

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Merve Şahin, PhD, RN

    Bergama Necla Mithat Öztüre State Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study used a pretest-posttest-follow-up randomised controlled experimental method. Participants were randomly assigned to either the experimental group (psychodrama-based group intervention) or the control group with no intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr. Ömer Uslu, PhD - Principal Investigator

Study Record Dates

First Submitted

December 13, 2025

First Posted

December 26, 2025

Study Start

April 2, 2025

Primary Completion

June 29, 2025

Study Completion

June 30, 2025

Last Updated

January 6, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) from this study will not be shared due to ethical and institutional restrictions. The dataset includes sensitive health information from postpartum women, and the informed consent process did not include permission for public data sharing. Therefore, in accordance with privacy regulations and ethical committee requirements, IPD will not be made available to other researchers

Locations